Abel Haley J, Oetjen Karolyn A, Miller Christopher A, Ramakrishnan Sai M, Day Ryan B, Helton Nichole M, Fronick Catrina C, Fulton Robert S, Heath Sharon E, Tarnawsky Stefan P, Srivatsan Sridhar Nonavinkere, Duncavage Eric J, Schroeder Molly C, Payton Jacqueline E, Spencer David H, Walter Matthew J, Westervelt Peter, DiPersio John F, Ley Timothy J, Link Daniel C
Division of Oncology, Department of Medicine, Washington University School of Medicine.
McDonnell Genome Institute, Washington University School of Medicine.
medRxiv. 2023 Jan 11:2023.01.10.23284322. doi: 10.1101/2023.01.10.23284322.
-mutated myeloid malignancies are most frequently associated with complex cytogenetics. The presence of complex and extensive structural variants complicates detailed genomic analysis by conventional clinical techniques. We performed whole genome sequencing of 42 AML/MDS cases with paired normal tissue to characterize the genomic landscape of -mutated myeloid malignancies. The vast majority of cases had multi-hit involvement at the genetic locus (94%), as well as aneuploidy and chromothripsis. Chromosomal patterns of aneuploidy differed significantly from -mutated cancers arising in other tissues. Recurrent structural variants affected regions that include on chr12p, on chr21, and on chr17q. Most notably for , transcript expression was low in cases of -mutated myeloid malignancies both with and without structural rearrangements involving chromosome 12p. Telomeric content is increased in -mutated AML/MDS compared other AML subtypes, and telomeric content was detected adjacent to interstitial regions of chromosomes. The genomic landscape of -mutated myeloid malignancies reveals recurrent structural variants affecting key hematopoietic transcription factors and telomeric repeats that are generally not detected by panel sequencing or conventional cytogenetic analyses.
WGS comprehensively determines mutation status, resulting in the reclassification of 12% of cases from mono-allelic to multi-hit Chromothripsis is more frequent than previously appreciated, with a preference for specific chromosomes is deleted in 45% of cases, with evidence for epigenetic suppression in non-deleted cases is mutated in 48% of cases, with multi-hit mutations in 17% of these cases -mutated AML/MDS is associated with altered telomere content compared with other AMLs.
全基因组测序全面确定 突变状态,导致12%的病例从单等位基因重新分类为多击 染色体碎裂比以前认识到的更频繁,并且偏好特定染色体 在45%的病例中缺失,在未缺失的病例中有表观遗传抑制的证据 在48%的病例中发生突变,其中17%的病例有多次突变 - 突变的AML/MDS与其他AML相比,端粒含量发生改变。